Bill > HB2945

This bill, known as the "Protecting Moms and Babies Act," establishes strict regulations on abortion-inducing drugs in Oklahoma, primarily focusing on prohibiting their manufacture, distribution, transportation, and provision. The bill defines an "abortion-inducing drug" as any substance prescribed with the intent of terminating a pregnancy, including specific medications like Mifeprex, misoprostol, and methotrexate. The legislation allows only qui tam (private party) actions to enforce these prohibitions, meaning individuals can sue on behalf of the state for violations. The bill creates several exceptions, such as using drugs to preserve the mother's life, remove ectopic pregnancies, or address medical conditions. Notably, the law provides significant financial incentives for qui tam plaintiffs, with potential awards of $100,000 per violation for certain plaintiffs like pregnant women, the father, sibling, or grandparent of the unborn child. The bill also includes extensive provisions to prevent other states from bringing "clawback" lawsuits against those who enforce this law and establishes specific jurisdictional rules that ensure Oklahoma courts have broad authority to hear such cases. The law is set to become effective on November 1, 2026, and includes a severability clause to ensure that if any part of the law is found invalid, the remaining provisions will still stand.

Justice

http://www.oklegislature.gov/BillInfo.aspx?Bill=hb2945&Session=2600